At the news
? BULLISHIMPACT 9/10 PRESS-RELEASE filed Mar 6, 2026 at 08:30 ET
Servier has agreed to acquire Day One Biopharmaceuticals (DAWN) for $21.50 per share in cash, representing a total equity value of approximately $2.5 billion. The offer includes a 68% premium over Day One's closing price on March 5, 2026, and is expected to close in Q2 2026, pending regulatory approval and shareholder tender.
- Servier is acquiring Day One Biopharmaceuticals for $21.50 per share in cash
- Total equity value of the transaction is approximately $2.5 billion
- Offer represents a 68% premium over DAWN's March 5, 2026 closing price and 86% over one-month VWAP
- Transaction expected to close in Q2 2026, subject to antitrust clearance and shareholder tender
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access